MacLennan WJ, Wilson J, Rattenhuber V, et al. Hydroxyethylrutosides in elderly patients with chronic venous insufficiency: its efficacy and tolerability.
Gerontology
1994;40:45-52.
Pulvertaft TB. Paroven in the treatment of chronic venous insufficiency.
Practitioner
. 1979;223:838-841.
Pulvertaft TB. General practice treatment of symptoms of venous insufficiency with oxerutins. Results of a 660 patient multicentre study in the UK.
Vasa.
1983;12:373-376.
Rehn D, Brunnauer H, Diebschlag W, et al. Investigation of the therapeutic equivalence of different galenical preparations of O-(beta-hydroxyethyl)-rutosides following multiple dose peroral administration.
Arzneimittelforschung.
1996;46:488-492.
Rehn D, Unkauf M, Klein P, et al. Comparative clinical efficacy and tolerability of oxerutins and horse chestnut extract in patients with chronic venous insufficiency.
Arzneimittelforschung.
1996;46:483-487.
Rehn D, Golden G, Nocker W, et al. Comparison between the efficacy and tolerability of oxerutins and troxerutin in the treatment of patients with chronic venous insufficiency.
Arzneimittelforschung.
1993;43:1060-1063.
Unkauf M, Rehn D, Klinger J, et al. Investigation of the efficacy of oxerutins compared to placebo in patients with chronic venous insufficiency treated with compression stockings.
Arzneimittelforschung.
1996;46:478-482.
Boisseau MR, Taccoen A, Garreau C, et al. Fibrinolysis and hemorheology in chronic venous insufficiency: a double blind study of troxerutin efficiency.
J Cardiovasc Surg (Torino).
1995;36:369-374.
Balmer A, Limoni C. A double blind placebo-controlled clinical trial of Venoruton on the symptoms and signs of chronic venous insufficiency. The importance of patient selection [in German].
Vasa.
1980;9:76-82.
Bergqvist D, Hallbk T, Lindblad B, et al. A double-blind trial of O-(beta-Hydroxyethyl)-Rutoside in patients with chronic venous insufficiency.
Vasa.
1981;10:253-260.
Anderson JH, Geraghty JG, Wilson YT, et al. Paroven and graduated compression hosiery for superficial venous insufficiency.
Phlebology
. 1990;5:271-276.
van Cauwenberge H. Double blind study of the efficacy of O(beta-hydroxyethyl)-rutosides in the treatment of venous conditions [in French].
Med Hyg (Geneve).
1978;36:4175-4177.
de Jongste AB, Jonker JJC, Huisman MV, et al. A double blind three center clinical trial on the short-term efficacy of 0-(beta-hydroxyethyl)-rutosides in patients with post-thrombotic syndrome.
Thromb Haemost.
1989;62:826-829.
Prerovsky I, Roztocil K, Hlavova A, et al. The effect of hydroxyethylrutosides after acute and chronic oral administration in patients with venous diseases. A double-blind study.
Angiologica
. 1972;9:408-414.
Cappelli R, Pecchi S, Oberhausser V, et al. Efficacy of O-(beta-hydroxyethy)-rutosides at high dosages in counteracting the unwanted activity of oral contraceptives on venous function.
Int J Clin Pharmacol Res
. 1987;7:291-299.
Stegmann W, Hubner K, Deichmann B, et al. The efficacy of O-(beta-hydroxyethyl)-rutosides in the treatment of venous leg ulcers [in French].
Phlebologie
. 1987;40:149-156.
Wadworth AN, Faulds D. Hydroxyethylrutosides. A review of its pharmacology, and therapeutic efficacy in venous insufficiency and related disorders.
Drugs.
1992;44:1013-1032.
Wright DD, Franks PJ, Blair SD, et al. Oxerutins in the prevention of recurrence in chronic venous ulceration: randomized controlled trial.
Br J Surg (England).
1991;78:1269-1270.
Sohn C, Jahnichen C, Bastert G. Effectiveness of beta-hydroxyethylrutoside in patients with varicose veins in pregnancy [in German].
Zentralbl Gynakol.
1995;117:190-197.
Bergstein NAM. Clinical study on the efficacy of O-(beta-Hydroxyethyl)Rutoside (HR) in varicosis of pregnancy.
J Int Med Res.
1975;3:189-193.
Wijayanegara H, Mose JC, Achmad L, et al. A clinical trial of hydroxyethylrutosides in the treatment of hemorrhoids of pregnancy.
J Int Med Res.
1992;20:54-60.
Wadworth AN, Faulds D. Hydroxyethylrutosides. A review of its pharmacology, and therapeutic efficacy in venous insufficiency and related disorders.
Drugs
. 1992;44:1013-1032.
Taylor HM, Rose KE, Twycross RG. A double-blind clinical trial of hydroxyethylrutosides in obstructive arm lymphoedema.
Phlebologie.
1993;(suppl 1):22-28.
Mortimer PS, Badger C, Clarke I, et al. A double-blind, randomized, parallel-group, placebo-controlled trial of O-(beta-Hydroxyethyl)-Rutosides in chronic arm oedema resulting from breast cancer treatment.
Phlebologie.
1995;10:51-55.
Piller NB, Morgan RG, Casley-Smith JR. A double-blind, cross-over trial of O-(beta-hydroxyethyl)-rutosides (benzo-pyrones) in the treatment of lymphoedema of the arms and legs.
Br J Plast Surg.
1988;41:20-27.
Fassina A, Rubinacci A. Post-traumatic oedemas. A controlled study into the activity of hydroxyethylrutoside [translated from Italian].
Gazz Med Ital Arch Sci.
1987;146:103-109.
Moser M, Ranacher G, Wilmot TJ, et al. A double-blind clinical trial of hydroxyethylrutosides in Meniere's disease.
J Laryngol Otol.
1984;98:265-272.
Wadworth AN, Faulds D. Hydroxyethylrutosides. A review of its pharmacology, and therapeutic efficacy in venous insufficiency and related disorders.
Drugs.
1992;44:1013-1032.
Pulvertaft TB. General practice treatment of symptoms of venous insufficiency with oxerutins. Results of a 660 patient multicentre study in the UK.
Vasa.
1983;12:373-376.
Unkauf M, Rehn D, Klinger J, et al. Investigation of the efficacy of oxerutins compared to placebo in patients with chronic venous insufficiency treated with compression stockings.
Arzneimittelforschung.
1996;46:478-482.
MacLennan WJ, Wilson J, Rattenhuber V, et al. Hydroxyethylrutosides in elderly patients with chronic venous insufficiency: its efficacy and tolerability.
Gerontology
1994;40:45-52.
Rehn D, Brunnauer H, Diebschlag W, et al. Investigation of the therapeutic equivalence of different galenical preparations of O-(beta-hydroxyethyl)-rutosides following multiple dose peroral administration.
Arzneimittelforschung.
1996;46:488-492.
Rehn D, Unkauf M, Klein P, et al. Comparative clinical efficacy and tolerability of oxerutins and horse chestnut extract in patients with chronic venous insufficiency.
Arzneimittelforschung.
1996;46:483-487.
Balmer A, Limoni C. A double blind placebo-controlled clinical trial of Venoruton on the symptoms and signs of chronic venous insufficiency. The importance of patient selection [in German].
Vasa.
1980;9:76-82.
Bergqvist D, Hallbook T, Lindblad B, et al. A double-blind trial of O-(beta-Hydroxyethyl)-Rutoside in patients with chronic venous insufficiency.
Vasa.
1981;10:253-260.
Anderson JH, Geraghty JG, Wilson YT, et al. Paroven and graduated compression hosiery for superficial venous insufficiency.
Phlebology
. 1990;5:271-276.
van Cauwenberge H. Double blind study of the efficacy of O(beta-hydroxyethyl)-rutosides in the treatment of venous conditions [in French].
Med Hyg (Geneve).
1978;36:4175-4177.
de Jongste AB, Jonker JJC, Huisman MV, et al. A double blind three center clinical trial on the short-term efficacy of 0-(beta-hydroxyethyl)-rutosides in patients with post-thrombotic syndrome.
Thromb Haemost.
1989;62:826-829.
Prerovsky I, Roztocil K, Hlavova A, et al. The effect of hydroxyethylrutosides after acute and chronic oral administration in patients with venous diseases. A double-blind study.
Angiologica
. 1972;9:408-414.
Cappelli R, Pecchi S, Oberhausser V, et al. Efficacy of O-(beta-hydroxyethy)-rutosides at high dosages in counteracting the unwanted activity of oral contraceptives on venous function.
Int J Clin Pharmacol Res
. 1987;7:291-299.
Boisseau MR, Taccoen A, Garreau C, et al. Fibrinolysis and hemorheology in chronic venous insufficiency: a double blind study of troxerutin efficiency.
J Cardiovasc Surg (Torino).
1995;36:369-374.
Rehn D, Golden G, Nocker W, et al. Comparison between the efficacy and tolerability of oxerutins and troxerutin in the treatment of patients with chronic venous insufficiency.
Arzneimittelforschung.
1993;43:1060-1063.
Bergstein NAM. Clinical study on the efficacy of O-(beta-Hydroxyethyl)Rutoside (HR) in varicosis of pregnancy.
J Int Med Res.
1975;3:189-193.
Sohn C, Jahnichen C, Bastert G. Effectiveness of beta-hydroxyethylrutoside in patients with varicose veins in pregnancy [in German].
Zentralbl Gynakol.
1995;117:190-197.
Stegmann W, Hubner K, Deichmann B, et al. The efficacy of O-(beta-hydroxyethyl)-rutosides in the treatment of venous leg ulcers [in French].
Phlebologie
. 1987;40:149-156.
Wadworth AN, Faulds D. Hydroxyethylrutosides. A review of its pharmacology, and therapeutic efficacy in venous insufficiency and related disorders.
Drugs.
1992;44:1013-1032.
Wadworth AN, Faulds D. Hydroxyethylrutosides. A review of its pharmacology, and therapeutic efficacy in venous insufficiency and related disorders.
Drugs.
1992;44:1013-1032.
Wright DD, Franks PJ, Blair SD, et al. Oxerutins in the prevention of recurrence in chronic venous ulceration: randomized controlled trial.
Br J Surg (England)
. 1991;78:1269-1270.
Wijayanegara H, Mose JC, Achmad L, et al. A clinical trial of hydroxyethylrutosides in the treatment of hemorrhoids of pregnancy.
J Int Med Res.
1992;20:54-60.
Piller NB, Morgan RG, Casley-Smith JR. A double-blind, cross-over trial of O-(beta-hydroxyethyl)-rutosides (benzo-pyrones) in the treatment of lymphoedema of the arms and legs.
Br J Plast Surg.
1988;41:20-27.
Taylor HM, Rose KE, Twycross RG. A double-blind clinical trial of hydroxyethylrutosides in obstructive arm lymphoedema.
Phlebologie.
1993;(suppl 1):22-28.
Mortimer PS, Badger C, Clarke I, et al. A double-blind, randomized, parallel-group, placebo-controlled trial of O-(beta-Hydroxyethyl)-Rutosides in chronic arm oedema resulting from breast cancer treatment.
Phlebologie.
1995;10:51-55.
Piller NB, Morgan RG, Casley-Smith JR. A double-blind, cross-over trial of O-(beta-hydroxyethyl)-rutosides (benzo-pyrones) in the treatment of lymphoedema of the arms and legs.
Br J Plast Surg.
1988;41:20-27.
Taylor HM, Rose KE, Twycross RG. A double-blind clinical trial of hydroxyethylrutosides in obstructive arm lymphoedema.
Phlebologie.
1993;(suppl 1):22-28.
Mortimer PS, Badger C, Clarke I, et al. A double-blind, randomized, parallel-group, placebo-controlled trial of O-(beta-Hydroxyethyl)-Rutosides in chronic arm oedema resulting from breast cancer treatment.
Phlebologie.
1995;10:51-55.
Fassina A, Rubinacci A. Post-traumatic oedemas. A controlled study into the activity of hydroxyethylrutoside [translated from Italian].
Gazz Med Ital Arch Sci.
1987;146:103-109.
MacLennan WJ, Wilson J, Rattenhuber V, et al. Hydroxyethylrutosides in elderly patients with chronic venous insufficiency: its efficacy and tolerability.
Gerontology
1994;40:45-52.
Wadworth AN, Faulds D. Hydroxyethylrutosides. A review of its pharmacology, and therapeutic efficacy in venous insufficiency and related disorders.
Drugs.
1992;44:1013-1032.
Petruzzellis V, Troccoli T, Candiani C, et al. Oxerutins (Venoruton): efficacy in chronic venous insufficiency—a double-blind, randomized, controlled study.
Angiology
. 2002;53:257-263.
Incandela L, Belcaro G, Renton S, et al. HR (Paroven, Venoruton; 0-(beta-hydroxyethyl)-rutosides) in venous hypertensive microangiopathy: A prospective, placebo-controlled, randomized trial.
J Cardiovasc Pharmacol Ther
. 2002;7(Suppl 1):S7-S10.
Incandela L, Cesarone MR, DeSanctis MT, et al. Treatment of diabetic microangiopathy and edema with HR (Paroven, Venoruton; 0-(beta-hydroxyethyl)-rutosides): A prospective, placebo-controlled, randomized study.
J Cardiovasc Pharmacol Ther
. 2002;7(Suppl 1):S11-S15.
Last reviewed July 2012 by EBSCO CAM Review Board
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.
Copyright © EBSCO Publishing. All rights reserved.